Innovative Nanocarriers for Stimulated Drug Delivery: A Comprehensive Guide to Stimuli-responsive Nanoparticles summarizes recent advances and achievements in nanocarriers responsive to external or internal stimuli. The book presents different stimuli-sensitive strategies and their applications in drug delivery, therapy, and theranostics. Sections provide fundamental knowledge on the experiential and experimental aspects of stimuli-responsive nanocarriers, discuss external-responsive nanocarriers for biomedical applications, such as ultrasound, thermal, magnetic, light, and electric field-response systems, and describe internal stimuli-responsive nanocarriers for biomedical applications, including pH, hypoxia, redox potential, enzyme, glucose, and microRNA-responsive nanocarriers.
Additionally, the book covers dual and multimodal-responsive nanocarriers and the therapeutic aspects of stimuli-responsive nanocarriers, such as metallic and non-metallic stimuli-responsive nanocarriers in the treatment of various cancer and noncancerous diseases. Finally, recent advances and regulatory aspects of stimuli-responsive nanocarriers, including clinical translation, challenges, biological toxicity, safety issues, clinical trials, and future perspectives are covered.
1. Chapter 2. History, introduction, and physicochemical properties and characterization parameters of stimuli-responsive nanocarriers - p. 33 2. Part II. External-responsive nanocarriers for biomedical application - p. P2 3. Chapter 3. Ultrasound-responsive nanocarriers for biomedical application - p. 75 4. 1 Introduction - p. 75 5. 2 Ultrasound-based drug delivery systems - p. 76 6. 3 Physics of ultrasound-based drug delivery system - p. 78 7. 4 Factors affecting ultrasound-mediated drug delivery - p. 78 8. 5 Different kinds of drug carriers - p. 80 9. 6 Classifications of NPs - p. 84 10. 7 Ultrasound and therapy - p. 95 11. Chapter 4. Magnetic-responsive nanocarriers for biomedical application - p. 131 12. Chapter 5. Light-sensitive nanocarriers for biomedical application - p. 155 13. Chapter 6. Electric field-response systems for biomedical application - p. 183 14. Chapter 7. Light-sensitive nanocarriers for Helicobacter pylori therapy - p. 213 15. Chapter 8. Sonodynamic therapy nanocarriers for helicobacter pylori therapy - p. 225 16. Part III. Internal stimuli-responsive nanocarriers for biomedical application - p. P3 17. Chapter 9. pH-responsive nanocarriers for biomedical application - p. 243 18. Chapter 10. Hypoxia-responsive nanocarriers for biomedical application - p. 269 19. Chapter 11. Azo-based compounds for hypoxia-responsive drug delivery - p. 299 20. Chapter 12. Redox-responsive nanocarriers for biomedical application - p. 333 21. Chapter 13. Enzyme-responsive nanocarriers: Revolutionizing biomedical applications - p. 353 22. Chapter 14. Glucose-responsive nanocarriers for biomedical application - p. 377 23. Chapter 15. microRNA responsive nanocarriers for biomedical applications - p. 415 24. Chapter 16. Peptide-responsive nanocarriers for biomedical applications - p. 467 25. Part IV. Dual and multimodal-responsive nanocarriers for biomedical application - p. P4 26. Chapter 17. pH-responsive nanocarriers: Smart drug delivery for biomedical applications - p. 491 27. Chapter 18. Biomedical applications of pH and redox dual-responsive nanocarriers - p. 513 28. Chapter 19. Dual-stimuli-responsive nanocarriers for biomedical application - p. 537 29. Chapter 20. Stimuli-responsive charge-reversal nanocarriers for biomedical application - p. 561 30. Chapter 21. Stimuli-responsive nanocarriers for image-guided therapy - p. 601 31. Part V. Therapeutic aspects of stimuli-responsive nanocarriers - p. P5 32. Chapter 22. Stimuli-responsive metal nanocarriers in the treatment of various cancers - p. 631 33. Chapter 23. Nonmetallic nanoparticles: A therapeutic platform for nonmalignant disorders - p. 653 34. Chapter 24. Nonmetallic stimuli-responsive nanocarriers in the treatment of noncancerous disease - p. 701 35. Part VI. Recent advances and regulatory aspects of stimuli-responsive nanocarriers - p. P6 36. Chapter 25. Clinical translation, challenges, biological toxicity, and safety issues associated with stimuli-responsive nanocarriers - p. 751 37. Chapter 26. Recent updates on clinical trials associated with stimuli-responsive nanocarriers - p. 785 38. Index - p. 835
Innovative Nanocarriers for Stimulated Drug Delivery: A Comprehensive Guide to Stimuli-responsive Nanoparticles summarizes recent advances and achievements in nanocarriers responsive to external or internal stimuli. The book presents different stimuli-sensitive strategies and their applications in drug delivery, therapy, and theranostics. Sections provide fundamental knowledge on the experiential and experimental aspects of stimuli-responsive nanocarriers, discuss external-responsive nanocarriers for biomedical applications, such as ultrasound, thermal, magnetic, light, and electric field-response systems, and describe internal stimuli-responsive nanocarriers for biomedical applications, including pH, hypoxia, redox potential, enzyme, glucose, and microRNA-responsive nanocarriers.
Additionally, the book covers dual and multimodal-responsive nanocarriers and the therapeutic aspects of stimuli-responsive nanocarriers, such as metallic and non-metallic stimuli-responsive nanocarriers in the treatment of various cancer and noncancerous diseases. Finally, recent advances and regulatory aspects of stimuli-responsive nanocarriers, including clinical translation, challenges, biological toxicity, safety issues, clinical trials, and future perspectives are covered.
1. Chapter 2. History, introduction, and physicochemical properties and characterization parameters of stimuli-responsive nanocarriers - p. 33 2. Part II. External-responsive nanocarriers for biomedical application - p. P2 3. Chapter 3. Ultrasound-responsive nanocarriers for biomedical application - p. 75 4. 1 Introduction - p. 75 5. 2 Ultrasound-based drug delivery systems - p. 76 6. 3 Physics of ultrasound-based drug delivery system - p. 78 7. 4 Factors affecting ultrasound-mediated drug delivery - p. 78 8. 5 Different kinds of drug carriers - p. 80 9. 6 Classifications of NPs - p. 84 10. 7 Ultrasound and therapy - p. 95 11. Chapter 4. Magnetic-responsive nanocarriers for biomedical application - p. 131 12. Chapter 5. Light-sensitive nanocarriers for biomedical application - p. 155 13. Chapter 6. Electric field-response systems for biomedical application - p. 183 14. Chapter 7. Light-sensitive nanocarriers for Helicobacter pylori therapy - p. 213 15. Chapter 8. Sonodynamic therapy nanocarriers for helicobacter pylori therapy - p. 225 16. Part III. Internal stimuli-responsive nanocarriers for biomedical application - p. P3 17. Chapter 9. pH-responsive nanocarriers for biomedical application - p. 243 18. Chapter 10. Hypoxia-responsive nanocarriers for biomedical application - p. 269 19. Chapter 11. Azo-based compounds for hypoxia-responsive drug delivery - p. 299 20. Chapter 12. Redox-responsive nanocarriers for biomedical application - p. 333 21. Chapter 13. Enzyme-responsive nanocarriers: Revolutionizing biomedical applications - p. 353 22. Chapter 14. Glucose-responsive nanocarriers for biomedical application - p. 377 23. Chapter 15. microRNA responsive nanocarriers for biomedical applications - p. 415 24. Chapter 16. Peptide-responsive nanocarriers for biomedical applications - p. 467 25. Part IV. Dual and multimodal-responsive nanocarriers for biomedical application - p. P4 26. Chapter 17. pH-responsive nanocarriers: Smart drug delivery for biomedical applications - p. 491 27. Chapter 18. Biomedical applications of pH and redox dual-responsive nanocarriers - p. 513 28. Chapter 19. Dual-stimuli-responsive nanocarriers for biomedical application - p. 537 29. Chapter 20. Stimuli-responsive charge-reversal nanocarriers for biomedical application - p. 561 30. Chapter 21. Stimuli-responsive nanocarriers for image-guided therapy - p. 601 31. Part V. Therapeutic aspects of stimuli-responsive nanocarriers - p. P5 32. Chapter 22. Stimuli-responsive metal nanocarriers in the treatment of various cancers - p. 631 33. Chapter 23. Nonmetallic nanoparticles: A therapeutic platform for nonmalignant disorders - p. 653 34. Chapter 24. Nonmetallic stimuli-responsive nanocarriers in the treatment of noncancerous disease - p. 701 35. Part VI. Recent advances and regulatory aspects of stimuli-responsive nanocarriers - p. P6 36. Chapter 25. Clinical translation, challenges, biological toxicity, and safety issues associated with stimuli-responsive nanocarriers - p. 751 37. Chapter 26. Recent updates on clinical trials associated with stimuli-responsive nanocarriers - p. 785 38. Index - p. 835
